Select Page

Analytical Development for nanodrugs

GTP Bioways provides expert services for the characterisation and formulation of a wide range of nanodrugs.

GTP Bioways CDMO - Antibody drug conjugate development

Expert analytical services for nanodrugs

To provide the highest quality services, our manufacturing is supported by integrated analytical capabilities and expertise.

We aim to deliver complete analytical packages customised for each phase and our services include the development and validation of analytical methods for the characterisation of even the most complex nano-formulated products.

Our goal is always to develop the most robust methods to ensure that the data generated conforms to regulatory requirements.

We offer a wide range of analytics capabilities for advanced characterisation of your nano-formulated product.

Cell line Development process

Cutting-edge analytical equipment for the characterisation of nano-formulated products

The control of  nano-formulated products requires the most cutting-edge analytical techniques.

Our analytical lab features advanced equipement to support product development and perform the characterisation of your product using methods such as:

    • dynamic light scattering
    • nanoparticle tracking analysis
    • zeta potential
    • infra-red and UV spectroscopy

ICH Stability studies for your nanodrug

We know that a well-designed, ICH-compliant stability programme is central to every drug development plan.

To complement our process development and manufacturing services, we offer stability packages, that are fully compliant with the regulatory requirements.

We design customised programmes for your nanodrug in order to  address its chemical, physical, or microbiological property changes.

GTP Bioways CDMO - Bioconjugates Analytical Development

Discover more about GTP Bioways services


GMP Manufacturing


Fill & Finish

GTP Bioways

Our approach

White paper

A Guide to Smooth CDMO Tech Transfer

The key parameters to be considered while choosing your next CDMO, as well as our tips to assess those parameters, and more!